A ‘groundbreaking’ ruling as appeal court orders US FDA to reconsider PMTA denial

In a big win for the vaping industry, a federal appellate court has ordered the US Food and Drug Administration (FDA) to reconsider its denial of premarket tobacco product applications (PMTAs) for six companies.

The 2-1 opinion by the US Court of Appeals for the 11th Circuit says the FDA erred when it issued marketing denial orders (MDOs) to Bidi Vapor, Diamond Vapor, Johnny Copper, Vapor Unlimited, Union Street Brands and Pop Vapor without considering the companies’ plans to prevent children from accessing their products.

Judges William Pryor and Andrew Brasher agreed that the MDOs were “arbitrary and capricious” and sent the PMTAs back to the FDA for further review. Lawyers for Bidi hailed the remand as “groundbreaking” and indicated the company might have a better chance of success in the next review.

...

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information

MORE INFO

Visit store

Check out our reports
available for purchase

View reports

Request a free sample of this report:

“ A ‘groundbreaking’ ruling as appeal court orders US FDA to reconsider PMTA denial ”

    This file is not available, please fill the form to request your sample page:






    Buy report request information:

    “ A ‘groundbreaking’ ruling as appeal court orders US FDA to reconsider PMTA denial ”






      In a big win for the vaping industry, a federal appellate court has ordered the US Food and Drug Administration (FDA) to reconsider its denial of premarket tobacco product applications (PMTAs) for six companies.

      The 2-1 opinion by the US Court of Appeals for the 11th Circuit says the FDA erred when it issued marketing denial orders (MDOs) to Bidi Vapor, Diamond Vapor, Johnny Copper, Vapor Unlimited, Union Street Brands and Pop Vapor without considering the companies’ plans to prevent children from accessing their products.

      Judges William Pryor and Andrew Brasher agreed that the MDOs were “arbitrary and capricious” and sent the PMTAs back to the FDA for further review. Lawyers for Bidi hailed the remand as “groundbreaking” and indicated the company might have a better chance of success in the next review.

      ...

      Benefits of subscription plans:

      • Stay informed of any legal and market change in the sector that impacts your organization
      • Maximise resources by getting market and legal data analysis daily in one place
      • Make smart decisions by understanding how the regulatory and market landscape evolves
      • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

      Need help?

      Contact a sales representative right now and don’t wait

      Erik Galavis
      +34 654 320 547
      Email Erik